Actionable tests and treatments for patients with gastrointestinal cancers and historically short median survival times.

Background: Patients have difficult unmet needs when standard chemotherapy produces a median survival of less than 1 year or many patients will experience severe toxicities. Blood tests can predict their survival.

Methods: Analyses evaluate predictive blood tests to identify patients who often survive 1 and 2 years.